NEW YORK, Sept 16 (IFR) - Bayer will be hoping that its
US$66bn purchase of Monsanto won't succumb to the same failure
that has tripped up many other mergers and acquisitions this
year, as regulators across the globe increase the scrutiny of
deals.
Read more
No comments:
Post a Comment